These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3774842)

  • 1. Coronary and pulmonary vascular effects of leukotrienes and PAF-acether.
    Goldstein RE; Ezra D; Laurindo FR; Feuerstein GZ
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():151-62. PubMed ID: 3774842
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effects of leukotrienes and PAF-acether electrophysiological activity of the rat retina.
    Doly M; Braquet P; Bonhomme B; Meyniel G
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():201-8. PubMed ID: 3022310
    [No Abstract]   [Full Text] [Related]  

  • 3. PAF-acether and leukotriene participation in acute circulatory shock.
    Bessin P
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():139-50. PubMed ID: 3774841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of drugs on leukotrienes-, PAF-acether- and histamine- induced contractions of guinea-pig lung parenchymal strips.
    Touvay C; Vilain B; Etienne A; Clostre F; Braquet P
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():91-110. PubMed ID: 3022312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene.
    Lefort J; Rotilio D; Vargaftig BB
    Br J Pharmacol; 1984 Jul; 82(3):565-75. PubMed ID: 6430375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cardiac and hemodynamic effects of platelet-activating factor-acether and leukotriene D4 in anesthetized dogs.
    Fiedler VB; Mardin M; Abram TS
    Basic Res Cardiol; 1987; 82(2):197-208. PubMed ID: 3606544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histamine and leukotriene-independent guinea-pig anaphylactic shock unaccounted for by Paf-acether.
    Detsouli A; Lefort J; Vargaftig BB
    Br J Pharmacol; 1985 Apr; 84(4):801-10. PubMed ID: 4005486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAF and leukotrienes '85. Proceedings of the meeting. Paris, September 27th 1985.
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():1-242. PubMed ID: 3774839
    [No Abstract]   [Full Text] [Related]  

  • 9. The actions of Paf-acether (platelet-activating factor) on guinea-pig isolated heart preparations.
    Benveniste J; Boullet C; Brink C; Labat C
    Br J Pharmacol; 1983 Sep; 80(1):81-3. PubMed ID: 6652376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence favouring PAF rather than leukotrienes in the pathogenesis of asthma.
    Page CP; Morley J
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():217-37. PubMed ID: 3774847
    [No Abstract]   [Full Text] [Related]  

  • 11. The causal role of PAF and leukotrienes in acute cardiac allograft rejection in rats.
    Foegh ML; Khirabadi BS; Rowles JR; Braquet P; Ramwell PW
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():127-32. PubMed ID: 3534895
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms of the coronary vascular effects of platelet-activating factor in the rat perfused heart.
    Hu W; Kinnaird AA; Man RY
    Br J Pharmacol; 1991 May; 103(1):1097-102. PubMed ID: 1652337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
    Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
    J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of vasoactive substances released by platelet-activating factor in the rat perfused heart.
    Hu WM; Man RY
    Br J Pharmacol; 1991 Dec; 104(4):933-7. PubMed ID: 1810604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAF-acether induced cardiac dysfunction in the isolated perfused guinea pig heart.
    Stahl GL; Lefer DJ; Lefer AM
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Oct; 336(4):459-63. PubMed ID: 3431598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-activating factor (PAF-acether) induced leukotriene C4 formation and luminol dependent chemiluminescence by human eosinophils.
    Bruynzeel PL; Koenderman L; Kok PT; Hameling ML; Verhagen J
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():61-9. PubMed ID: 3774850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of platelet-activating factor (PAF-acether) and leukotrienes C and D from inflammatory macrophages.
    Roubin R; Mencia-Huerta JM; Benveniste J
    Eur J Immunol; 1982 Feb; 12(2):141-6. PubMed ID: 6122581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of PAF-acether (platelet activating factor) in cardio-vascular pathology].
    Gateau O
    Arch Mal Coeur Vaiss; 1987 May; 80 Spec No():51-2. PubMed ID: 3117010
    [No Abstract]   [Full Text] [Related]  

  • 19. Exudative, cellular and humoral reactions to platelet-activating factor (PAF-acether) in the pleural cavity of rats.
    Tarayre JP; Delhon A; Bruniquel F; Puech L; Tisne-Versailles J; Couzinier JP
    Eur J Pharmacol; 1986 May; 124(3):317-23. PubMed ID: 3755401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of platelet-activating factor on porcine pulmonary blood vessels in vitro.
    Pritze S; Simmet T; Peskar BA
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):495-9. PubMed ID: 1766475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.